Mortality in Germany during the COVID-19 Pandemic.

COVID-19 excess mortality improving mortality rates parametric mortality models

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
19 10 2023
Historique:
received: 28 08 2023
revised: 12 10 2023
accepted: 17 10 2023
medline: 30 10 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

Is there sufficient scientific evidence for excess mortality caused by COVID-19? The German population, similar to the population of many other countries, is subject to fluctuations caused by multiple factors, including migration and aging. COVID-19 is one additional factor, superposing natural or seasonal mortality fluctuations. To give scientific evidence for excess mortality caused by COVID-19, it is essential to employ appropriate statistical tools. This study develops a score indicating excess mortality and studies its evolution over time. Applied to data provided by governmental authorities, the indicator discloses, without relating to causes of death explicitly, excess mortality at the end of 2020, in 2021, and in 2022. In addition, the indicator confirms that COVID-19 particularly impacted the elderly segment of the population.

Identifiants

pubmed: 37887680
pii: ijerph20206942
doi: 10.3390/ijerph20206942
pmc: PMC10606421
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Environ Res Public Health. 2022 Nov 30;19(23):
pubmed: 36498078
Nat Med. 2020 Dec;26(12):1919-1928
pubmed: 33057181
PLoS One. 2021 Feb 5;16(2):e0246663
pubmed: 33544767
Popul Dev Rev. 2022 Jun;48(2):279-302
pubmed: 35600716
PLoS One. 2021 Aug 3;16(8):e0255540
pubmed: 34343210
N Am Actuar J. 2011;15(3):432-447
pubmed: 22308064
Int J Environ Res Public Health. 2023 Jan 20;20(3):
pubmed: 36767340
Elife. 2021 Jun 30;10:
pubmed: 34190045
Lancet. 2022 Apr 16;399(10334):1513-1536
pubmed: 35279232
Int J Epidemiol. 1985 Mar;14(1):124-9
pubmed: 3988427
Int J Epidemiol. 2022 Feb 18;51(1):35-53
pubmed: 34282450
Int J Environ Res Public Health. 2023 Oct 19;20(20):
pubmed: 37887680
Int J Environ Res Public Health. 2023 Feb 04;20(4):
pubmed: 36833477

Auteurs

Alois Pichler (A)

Faculty of Mathematics, University of Technology Chemnitz, 09111 Chemnitz, Germany.

Dana Uhlig (D)

Faculty of Mathematics, University of Technology Chemnitz, 09111 Chemnitz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH